BOD Australia Ltd
ASX:BOD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
BOD Australia Ltd
Net Income (Common)
BOD Australia Ltd
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
BOD Australia Ltd
ASX:BOD
|
Net Income (Common)
AU$259k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Recce Pharmaceuticals Ltd
ASX:RCE
|
Net Income (Common)
-AU$30.3m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
Net Income (Common)
-AU$93.8m
|
CAGR 3-Years
31%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Net Income (Common)
AU$30.4m
|
CAGR 3-Years
449%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Net Income (Common)
-AU$64.3m
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-56%
|
CAGR 10-Years
N/A
|
|
|
Vita Life Sciences Ltd
ASX:VLS
|
Net Income (Common)
AU$10.4m
|
CAGR 3-Years
14%
|
CAGR 5-Years
11%
|
CAGR 10-Years
9%
|
|
BOD Australia Ltd
Glance View
Bod Australia Ltd. operates as a developer, manufacturer, distributor, importer, exporter and marketer of skincare, beauty, and health industries for the natural segment of the market. The company is headquartered in Sydney, New South Wales. The company went IPO on 2016-10-27. The firm is engaged in the development and manufacture of cannabidiol (CBD) and hemp products for consumer markets in Australia and United Kingdom, as well as the development, manufacture and distribution of therapeutics medicinal cannabis products. The firm operates through three segments: medical, over the counter cannabidiol/Hemp (OTC CBD/Hemp) and OTC Herbals.
See Also
What is BOD Australia Ltd's Net Income (Common)?
Net Income (Common)
259k
AUD
Based on the financial report for Jun 30, 2025, BOD Australia Ltd's Net Income (Common) amounts to 259k AUD.
